Gerjo J. De Knegt
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Mycobacterium tuberculosis clinical isolates of the Beijing and East-African Indian lineage induce fundamentally different host responses in mice compared to H37Rv.
Journal: Scientific reports
Published: August 22, 2019
Assessment of the Additional Value of Verapamil to a Moxifloxacin and Linezolid Combination Regimen in a Murine Tuberculosis Model.
Journal: Antimicrobial agents and chemotherapy
Published: June 25, 2018
Improving treatment outcome assessment in a mouse tuberculosis model.
Journal: Scientific reports
Published: November 15, 2017
The Role of Efflux Pumps in Tuberculosis Treatment and Their Promise as a Target in Drug Development: Unraveling the Black Box.
Journal: Annual review of pharmacology and toxicology
Published: July 19, 2017
Assessment of Bactericidal Drug Activity and Treatment Outcome in a Mouse Tuberculosis Model Using a Clinical Beijing Strain.
Journal: Antimicrobial agents and chemotherapy
Published: April 03, 2017
Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 10, 2017
Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: November 14, 2016
Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis.
Journal: American journal of respiratory cell and molecular biology
Published: September 23, 2016
Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.
Journal: International journal of antimicrobial agents
Published: July 04, 2016
Inhibitory potential of tuberculosis drugs on ATP-binding cassette drug transporters.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: March 17, 2015
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: January 27, 2015
SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model.
Journal: International journal of antimicrobial agents
Published: January 13, 2015
Last Updated: 09/26/2026